Last Updated
Case Status
Pending
Federal Trade Commission and State of Georgia, Plaintiffs, v. Steven D. Peyroux, individually and as an owner and officer of Regenerative Medicine Institute of America, LLC, also d/b/a Stem Cell Institute of America, LLC, Physicians Business Solutions, LLC, and Superior Healthcare, LLC, Brent J. Detelich, Individually and as an officer of Regenerative Medicine Institute of America, LLC, also d/b/a Stem Cell Institute of America, LLC, Regenerative Medicine Institute of America, LLC, a limited liability company, also d/b/a Stem Cell Institute of America, LLC, Physicians Business Solutions, LLC, a limited liability company, and Superior Healthcare, LLC, a limited liability company, Defendants.
FTC Matter/File Number
182 3125
Civil Action Number
1:21-cv-03329-AT
Federal Court
Northern District of Georgia
Case Summary
In August 2021, the FTC and the Georgia Attorney General’s Office sued the co-founders of the Stem Cell Institute of America for marketing stem cell therapy to seniors nationwide using bogus claims that it is effective in treating arthritis, joint pain, and a range of other orthopedic ailments. In January 2025 the FTC and AG’s Office announce two court orders in their favor settling the complaint and barring the company from the allegedly illegal conduct.